Congressional Report Highlights FDA’s Role in Emerging Hemp Markets

Congressional Report Highlights FDA’s Role in Emerging Hemp Markets

A

Membership required to view content.
issued Friday by the Congressional Research Service (CRS) provides a broad overview of the development of the hemp industry, specifically floral hemp and its associated extracts like CBD. 

The report highlights the role of the FDA in the emerging hemp industry, and its failure to create a regulatory pathway for CBD.  It noted that after years of review by a high-level internal working group, the FDA announced in January it would work with Congress to create a new regulatory pathway for CBD. 

Membership is required to view the rest of this post.
Click here to learn more and sign up for a free 7-day trial!

Blog

02.04.2025

Chicago, Gulf animal fats and oils markets strengthen despite ongoing uncertainty

Chicago, Gulf animal fats and oils markets strengthen despite ongoing uncertainty

The US animal fats and oils markets were stable to higher on Tuesday February 4, as Chicago market activity saw a notable uptick throughout the day.

Six railcars...

02.04.2025

Light trade volume leaves most US animal protein prices flat

Light trade volume leaves most US animal protein prices flat

Light trade volume was reported in the US animal proteins markets for Tuesday February 4.

Ruminant meat and bonemeal, Missouri River, was reported as steady from Monday February...

02.04.2025

December US soybean crush, corn consumption up month on month

December US soybean crush, corn consumption up month on month

US soybean crush above monthly, yearly levels
Soybeans crushed for crude oil totaled 218 million bushels in December 2024, up by 7% from November and by 4% from...

Latest Tweets